In support of the DYT-PRKRA dystonia symptoms possibly being a result of IFN overproduction, it has been documented that people undergoing type I IFN therapy for hepatitis B and C develop dystonia as a side effect [63,64]. This evidence concerns the gene IFNA1 and Dystonia.